SCHEMBL10747607

SCHEMBL10747607

S=c1c2ccccc2[se]n1-c1cccc2cnccc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.41
▸ LMNA P02545 1/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ MAPKAPK2 P49137 1/20 0.41
▸ HTT P42858 1/20 0.38
▸ ADRA2A P08913 1/20 0.36
▸ ADRA2B P18089 1/20 0.36
▸ ADRA2C P18825 1/20 0.36
▸ ADRA1A P35348 1/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ MAPT P10636 2/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ METAP2 P50579 1/20 0.35
▸ P2RX7 Q99572 1/20 0.35
▸ NPC1 O15118 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5916590 0.83 METAP2 (0.55) KDM4ELMNACYP3A4CYP2D6CYP2C9
SCHEMBL10748399 0.76 CYP3A4 (0.39) KDM4ELMNACYP3A4ALDH1A1MAPT
SCHEMBL10748809 0.76 CYP3A4 (0.46) KDM4ELMNACYP1A2CYP3A4CYP2D6
SCHEMBL10502470 0.74 METAP2 (0.46) KDM4ELMNACYP3A4CYP2D6CYP2C9
SCHEMBL10746610 0.74 MAPK1 (0.43) KDM4ECYP1A2CYP3A4CYP2C19ALDH1A1
SCHEMBL10502592 0.74 ALDH1A1 (0.42) KDM4ELMNACYP3A4CYP2D6CYP2C9
SCHEMBL10746688 0.72 KDM4E (0.35) KDM4ELMNACYP3A4CYP2D6CYP2C9
SCHEMBL10501640 0.71 METAP2 (0.37) KDM4ELMNACYP3A4CYP2D6CYP2C9
SCHEMBL10502616 0.71 METAP2 (0.46) KDM4ELMNACYP3A4CYP2D6CYP2C9
SCHEMBL10502354 0.71 METAP2 (0.41) KDM4ELMNACYP3A4CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4711961-A Benzisoselenazolethiones and process for the treatment of various diseases in humans A. NATTERMANN & CIE GMBH (DE) 1987-12-08 — — US disclosed
EP-0154851-A1 Benzisoselenazolethiones,process for their preparation and pharmaceutical products containing these compounds A. Nattermann & Cie. GmbH (DE) 1985-09-18 — — EP disclosed
Send feedback